Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 May;94(1):37–46. doi: 10.1111/j.1476-5381.1988.tb11497.x

A study of the actions of P1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro.

A G Blakeley 1, P M Dunn 1, S A Petersen 1
PMCID: PMC1853933  PMID: 3401642

Abstract

1. We have examined the effects of purinoceptor agonists and antagonists on the mechanical 'twitch' response, excitatory junction potential (e.j.p.) amplitude and [3H]-noradrenaline overflow in the mouse vas deferens. 2. The agonist profile for inhibition of the mechanical response was N6-([R]-2-phenylisopropyl)adenosine (L-PIA) congruent to N6-cyclohexyladenosine (CHA) greater than 5' N-ethylcarboxamido-adenosine (NECA) greater than 2-chloroadenosine (2ClA) congruent N6-([S]-2-phenylisopropyl)adenosine (D-PIA). 3. The P1-purinoceptor agonists inhibited the e.j.p. with an agonist profile of CHA greater than L-PIA congruent to NECA greater than 2ClA. 4. 2ClA inhibited [3H]-noradrenaline overflow with an EC50 of 1.2 microM which was not significantly different from the values for inhibition of the e.j.p. and the mechanical response. 5. The inhibitory action of 2ClA on the mechanical response was antagonized by 5 microM 8-phenyltheophylline (8-PT). However, neither blockade of P1-purinoceptors by 8-PT nor increasing the rate of degradation of endogenous adenosine by addition of adenosine deaminase had any effect on the mechanical response per se. 8-PT (5 microM) also failed to alter the e.j.p. amplitude or [3H]-noradrenaline overflow. 6. These results indicate that there are P1-purinoceptors present on sympathetic nerve terminals of the mouse vas deferens which are more like A1- than A2-receptors, but may be better classified as being of the A3-subtype (Ribeiro & Sebastiao, 1986). These receptors are not normally involved in the feedback regulation of transmitter release in this tissue.

Full text

PDF
37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blakeley A. G., Cunnane T. C. The packeted release of transmitter from the sympathetic nerves of the guinea-pig vas deferens: an electrophysiological study. J Physiol. 1979 Nov;296:85–96. doi: 10.1113/jphysiol.1979.sp012992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blakeley A. G., Mathie A., Petersen S. A. Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens. Br J Pharmacol. 1986 Aug;88(4):807–814. doi: 10.1111/j.1476-5381.1986.tb16253.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bruns R. F., Daly J. W., Snyder S. H. Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5547–5551. doi: 10.1073/pnas.77.9.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clanachan A. S., Johns A., Paton D. M. Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens. Neuroscience. 1977;2(4):597–602. doi: 10.1016/0306-4522(77)90056-2. [DOI] [PubMed] [Google Scholar]
  5. Enero M. A., Saidman B. Q. Possible feed-back inhibition of noradrenaline release by purine compounds. Naunyn Schmiedebergs Arch Pharmacol. 1977 Mar;297(1):39–46. doi: 10.1007/BF00508808. [DOI] [PubMed] [Google Scholar]
  6. Espinal J., Challiss R. A., Newsholme E. A. Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett. 1983 Jul 11;158(1):103–106. doi: 10.1016/0014-5793(83)80685-1. [DOI] [PubMed] [Google Scholar]
  7. Fredholm B. B., Hedqvist P. Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol. 1980 Jun 15;29(12):1635–1643. doi: 10.1016/0006-2952(80)90117-3. [DOI] [PubMed] [Google Scholar]
  8. French A. M., Scott N. C. Evidence to support the hypothesis that ATP is a co-transmitter in rat vas deferens. Experientia. 1983 Mar 15;39(3):264–266. doi: 10.1007/BF01955295. [DOI] [PubMed] [Google Scholar]
  9. Ginsborg B. L., Hirst G. D. The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat. J Physiol. 1972 Aug;224(3):629–645. doi: 10.1113/jphysiol.1972.sp009916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gliemann J., Bowes S. B., Larsen T. R., Rees W. D. The effect of catecholamines and adenosine deaminase on the glucose transport system in rat adipocytes. Biochim Biophys Acta. 1985 Jun 30;845(3):373–379. doi: 10.1016/0167-4889(85)90201-0. [DOI] [PubMed] [Google Scholar]
  11. Griffith S. G., Meghji P., Moody C. J., Burnstock G. 8-phenyltheophylline: a potent P1-purinoceptor antagonist. Eur J Pharmacol. 1981 Oct 15;75(1):61–64. doi: 10.1016/0014-2999(81)90346-0. [DOI] [PubMed] [Google Scholar]
  12. Gustafsson L. E., Wiklund N. P., Cederqvist B. Apparent enhancement of cholinergic transmission in rabbit bronchi via adenosine A2 receptors. Eur J Pharmacol. 1986 Jan 21;120(2):179–185. doi: 10.1016/0014-2999(86)90538-8. [DOI] [PubMed] [Google Scholar]
  13. Henon B. K., McAfee D. A. The ionic basis of adenosine receptor actions on post-ganglionic neurones in the rat. J Physiol. 1983 Mar;336:607–620. doi: 10.1113/jphysiol.1983.sp014600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jackisch R., Fehr R., Hertting G. Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology. 1985 Jun;24(6):499–507. doi: 10.1016/0028-3908(85)90055-3. [DOI] [PubMed] [Google Scholar]
  15. Londos C., Cooper D. M., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980 May;77(5):2551–2554. doi: 10.1073/pnas.77.5.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Long C. J., Stone T. W. The effects of adenosine on receptor sensitivity in the rat vas deferens. Eur J Pharmacol. 1986 Dec 2;132(1):11–19. doi: 10.1016/0014-2999(86)90003-8. [DOI] [PubMed] [Google Scholar]
  17. MacDonald R. L., Skerritt J. H., Werz M. A. Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture. J Physiol. 1986 Jan;370:75–90. doi: 10.1113/jphysiol.1986.sp015923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Marshall I., Nasmyth P. A., Shepperson N. B. The effects of release and depletion of endogenous noradrenaline on the transmission of impulses in the mouse vas deferens. Br J Pharmacol. 1978 Sep;64(1):145–151. doi: 10.1111/j.1476-5381.1978.tb08651.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marshall I. Stimulation-evoked release of [3H]-noradrenaline by 1, 10 or 100 pulses and its modification through presynaptic alpha 2-adrenoceptors. Br J Pharmacol. 1983 Jan;78(1):221–231. doi: 10.1111/j.1476-5381.1983.tb09383.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meldrum L. A., Burnstock G. Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferens. Eur J Pharmacol. 1983 Aug 19;92(1-2):161–163. doi: 10.1016/0014-2999(83)90126-7. [DOI] [PubMed] [Google Scholar]
  21. Paton D. M. Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors. J Auton Pharmacol. 1981 Sep;1(4):287–290. doi: 10.1111/j.1474-8673.1981.tb00457.x. [DOI] [PubMed] [Google Scholar]
  22. Ramme D., Illes P. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):57–61. doi: 10.1007/BF00633197. [DOI] [PubMed] [Google Scholar]
  23. Ribeiro J. A., Sebastião A. M. Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor. Prog Neurobiol. 1986;26(3):179–209. doi: 10.1016/0301-0082(86)90015-8. [DOI] [PubMed] [Google Scholar]
  24. Ribeiro J. A., Sebastião A. M. On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction. Br J Pharmacol. 1985 Apr;84(4):911–918. doi: 10.1111/j.1476-5381.1985.tb17385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sneddon P., Burnstock G. Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol. 1984 Apr 13;100(1):85–90. doi: 10.1016/0014-2999(84)90318-2. [DOI] [PubMed] [Google Scholar]
  26. Sneddon P., Meldrum L. A., Burnstock G. Control of transmitter release in guinea-pig vas deferens by prejunctional P1-purinoceptors. Eur J Pharmacol. 1984 Oct 15;105(3-4):293–299. doi: 10.1016/0014-2999(84)90621-6. [DOI] [PubMed] [Google Scholar]
  27. Sneddon P., Westfall D. P. Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol. 1984 Feb;347:561–580. doi: 10.1113/jphysiol.1984.sp015083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stjärne L., Lundberg J. M., Astrand P. Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience. 1986 May;18(1):151–166. doi: 10.1016/0306-4522(86)90184-3. [DOI] [PubMed] [Google Scholar]
  29. Su C. Purinergic inhibition of adrenergic transmission in rabbit blood vessels. J Pharmacol Exp Ther. 1978 Feb;204(2):351–361. [PubMed] [Google Scholar]
  30. Westfall D. P., Stitzel R. E., Rowe J. N. The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur J Pharmacol. 1978 Jul 1;50(1):27–38. doi: 10.1016/0014-2999(78)90250-9. [DOI] [PubMed] [Google Scholar]
  31. van Calker D., Müller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979 Nov;33(5):999–1005. doi: 10.1111/j.1471-4159.1979.tb05236.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES